These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26351030)

  • 1. Obligatory Role for B Cells in the Development of Angiotensin II-Dependent Hypertension.
    Chan CT; Sobey CG; Lieu M; Ferens D; Kett MM; Diep H; Kim HA; Krishnan SM; Lewis CV; Salimova E; Tipping P; Vinh A; Samuel CS; Peter K; Guzik TJ; Kyaw TS; Toh BH; Bobik A; Drummond GR
    Hypertension; 2015 Nov; 66(5):1023-33. PubMed ID: 26351030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase.
    Wu J; Thabet SR; Kirabo A; Trott DW; Saleh MA; Xiao L; Madhur MS; Chen W; Harrison DG
    Circ Res; 2014 Feb; 114(4):616-25. PubMed ID: 24347665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences and role of lysyl oxidase-like 2 in angiotensin II-induced hypertension in mice.
    Wang H; Martinez Yus M; Brady T; Choi R; Nandakumar K; Smith L; Jang R; Wodu BP; Almodiel JD; Stoddart L; Kim DH; Steppan J; Santhanam L
    Am J Physiol Heart Circ Physiol; 2024 Sep; 327(3):H642-H659. PubMed ID: 39028284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. γδ T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury.
    Caillon A; Mian MOR; Fraulob-Aquino JC; Huo KG; Barhoumi T; Ouerd S; Sinnaeve PR; Paradis P; Schiffrin EL
    Circulation; 2017 May; 135(22):2155-2162. PubMed ID: 28330983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopause and FOXP3
    Pollow DP; Uhlorn JA; Sylvester MA; Romero-Aleshire MJ; Uhrlaub JL; Lindsey ML; Nikolich-Zugich J; Brooks HL
    Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H415-H423. PubMed ID: 31099612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
    Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
    Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signals from activation of B-cell receptor with anti-IgD can override the stimulatory effects of excess BAFF on mature B cells in vivo.
    Nguyen TG; Morris JM
    Immunol Lett; 2014 Sep; 161(1):157-64. PubMed ID: 24954638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct angiotensin II type 2 receptor stimulation in Nω-nitro-L-arginine-methyl ester-induced hypertension: the effect on pulse wave velocity and aortic remodeling.
    Paulis L; Becker ST; Lucht K; Schwengel K; Slavic S; Kaschina E; Thöne-Reineke C; Dahlöf B; Baulmann J; Unger T; Steckelings UM
    Hypertension; 2012 Feb; 59(2):485-92. PubMed ID: 22215717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenocyte transfer from hypertensive donors eliminates premenopausal female protection from ANG II-induced hypertension.
    Sylvester MA; Pollow DP; Moffett C; Nunez W; Uhrlaub JL; Nikolich-Zugich J; Brooks HL
    Am J Physiol Renal Physiol; 2022 Mar; 322(3):F245-F257. PubMed ID: 35001661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescue of the mature B cell compartment in BAFF-deficient mice by treatment with recombinant Fc-BAFF.
    Swee LK; Tardivel A; Schneider P; Rolink A
    Immunol Lett; 2010 Jun; 131(1):40-8. PubMed ID: 20350570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuated responses to angiotensin II in follitropin receptor knockout mice, a model of menopause-associated hypertension.
    Javeshghani D; Touyz RM; Sairam MR; Virdis A; Neves MF; Schiffrin EL
    Hypertension; 2003 Oct; 42(4):761-7. PubMed ID: 12885794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of T-regulatory cells exaggerates angiotensin II-induced microvascular injury by enhancing immune responses.
    Mian MO; Barhoumi T; Briet M; Paradis P; Schiffrin EL
    J Hypertens; 2016 Jan; 34(1):97-108. PubMed ID: 26630215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling.
    Ishibashi M; Hiasa K; Zhao Q; Inoue S; Ohtani K; Kitamoto S; Tsuchihashi M; Sugaya T; Charo IF; Kura S; Tsuzuki T; Ishibashi T; Takeshita A; Egashira K
    Circ Res; 2004 May; 94(9):1203-10. PubMed ID: 15059935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class A scavenger receptor deficiency augments angiotensin II-induced vascular remodeling.
    Qian L; Li X; Fang R; Wang Z; Xu Y; Zhang H; Bai H; Yang Q; Zhu X; Ben J; Xu Y; Chen Q
    Biochem Pharmacol; 2014 Aug; 90(3):254-64. PubMed ID: 24875449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential phenotypes of tissue-infiltrating T cells during angiotensin II-induced hypertension in mice.
    Wei Z; Spizzo I; Diep H; Drummond GR; Widdop RE; Vinh A
    PLoS One; 2014; 9(12):e114895. PubMed ID: 25501574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis.
    Wenzel UO; Thaiss F; Helmchen U; Stahl RA; Wolf G
    Kidney Int; 2002 Mar; 61(3):1020-9. PubMed ID: 11849457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension.
    Javeshghani D; Sairam MR; Neves MF; Schiffrin EL; Touyz RM
    J Hypertens; 2006 Jul; 24(7):1365-73. PubMed ID: 16794486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lysyl oxidase inhibition on angiotensin II-induced arterial hypertension, remodeling, and stiffness.
    Eberson LS; Sanchez PA; Majeed BA; Tawinwung S; Secomb TW; Larson DF
    PLoS One; 2015; 10(4):e0124013. PubMed ID: 25875748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
    Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
    Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen-androgen receptor system protects against angiotensin II-induced vascular remodeling.
    Ikeda Y; Aihara K; Yoshida S; Sato T; Yagi S; Iwase T; Sumitomo Y; Ise T; Ishikawa K; Azuma H; Akaike M; Kato S; Matsumoto T
    Endocrinology; 2009 Jun; 150(6):2857-64. PubMed ID: 19196803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.